Sudarshan Pharma Industries has received approval to acquire 10,000 ordinary shares of Singapore Dollar 1 each of Sudarshan Pharma Industries, a company incorporated in Singapore (100% of the paid-up share capital of Sudarshan Pharma Industries). Upon completion of the acquisition, Sudarshan Pharma Industries, Singapore would become a wholly-owned subsidiary of the company.
The acquisition will help the company to expand its business operations in Singapore and other neighbouring countries. The Board of Directors of the Company has, on November 28, 2024, approved same.
Sudarshan Pharma Industries is engaged in contract manufacturing, outsource & Supply of Generic Pharma formulation and medicines to healthcare institution, Government, NGO and Hospitals.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1696.65 |
| Dr. Reddys Lab | 1218.30 |
| Cipla | 1226.65 |
| Zydus Lifesciences | 936.00 |
| Lupin | 2339.20 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: